MOUNTAIN VIEW, CA–( EMWNews – April 1, 2008) – Hansen Medical, Inc. (NASDAQ: HNSN) today

announced that it has priced its public offering of 3,000,000 shares of its

common stock. The offering was increased to 3,000,000 shares from

2,500,000 shares. Morgan Stanley & Co. Incorporated will be the sole

underwriter for the offering.

The underwriter may offer the shares from time to time in one or more

transactions in the over-the-counter market or through negotiated

transactions at market prices or at negotiated prices. The offering is

being made pursuant to a shelf registration statement that became effective

on March 17, 2008.

This press release does not constitute an offer to sell or the solicitation

of an offer to buy any of the securities, nor shall there be any sale of

the securities in any state in which such offer, solicitation or sale would

be unlawful prior to registration or qualification under the securities

laws of such state. A prospectus supplement relating to the offering will

be filed with the Securities and Exchange Commission. When available,

copies of the prospectus supplement and accompanying base prospectus may be

obtained upon request to Morgan Stanley & Co. Incorporated, 180 Varick

Street, New York, New York 10014, Attention Prospectus Department

(telephone: 866.718.1649), or by e-mail at [email protected].

About Hansen Medical

Hansen Medical, based in Mountain View, Calif., was founded in 2002 to

develop products and technology using robotics for the accurate

positioning, manipulation and stable control of catheters and

catheter-based technologies. The Sensei Robotic Catheter System™ and

Artisan Control Catheter™ are cleared by the FDA to guide pre-approved

percutaneous catheters for mapping anatomy of the heart. Additional

information can be found at www.hansenmedical.com. Hansen Medical

has pending trademark applications for “Hansen Medical,” “Sensei,”

“Artisan,” “Hansen Artisan,” as well as the Hansen Medical “heart design”

logo. Hansen Medical, Hansen Medical Heart Design logo, Sensei, Artisan,

Instinctive Motion, IntelliSense, and Fine Force Technology are trademarks

of Hansen Medical, Inc. in the United States and other countries. All

trademarks and registered trademarks are property of their respective

owners.

Forward-Looking Statements

This press release contains forward-looking statements. We intend such

forward-looking statements to be covered by the safe harbor provisions for

forward-looking statements contained in Section 21E of the Exchange Act and

the Private Securities Litigation Reform Act of 1995. These statements are

based on the current estimates and assumptions of our management as of the

date of this press release and are subject to risks, uncertainties, changes

in circumstances, assumptions and other factors that may cause actual

results to differ materially from those indicated by forward-looking

statements. Factors that might cause such differences include those

described in under the heading “Risk Factors” contained in Item 1A of our

Annual Report on Form 10-K for the fiscal year ended December 31, 2007

filed with the Securities and Exchange Commission (SEC) on February 28,

2008 and the risks discussed in our other filings with the SEC. We

undertake no obligation to revise or update information the forward-looking

information contained in this press release.